Pozo et al. [77] reported that transgenic mice engineered to overexpress p25 (a hyperactive form of p35) in thyroid C cells developed medullary thyroid carcinoma (MTC). This evidence concerns the gene CDK5R1 and medullary thyroid gland carcinoma.